PNC Financial Services Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PNC Financial Services Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-362	Closed	-$42K	–	4203
2019 Q4	$42K	Sell	362 -13,214	-97%	-$1.53M	﹤0.01%	2999
2019 Q3	$1.55M	Buy	+13,576	New	+$1.35M	﹤0.01%	1079
2016 Q4	–	Sell	-576	Closed	-$72K	–	4192
2016 Q3	$72K	Buy	+576	New	+$68K	﹤0.01%	2639
2015 Q2	–	Sell	-1,637	Closed	-$157K	–	4833
2015 Q1	$157K	Sell	1,637 -3,285	-67%	-$246K	﹤0.01%	2417
2014 Q4	$330K	Buy	+4,922	New	+$305K	﹤0.01%	1774

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PNC Financial Services Group's CBPO Position: Q1 2020 in Review

PNC Financial Services Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 362 shares — an estimated $42K sold.

PNC Financial Services Group first reported a position in CBPO in Q4 2014 and held it in 5 quarters. The position peaked at $1.55M in Q3 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

PNC Financial Services Group reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
PNC Financial Services Group sold 362 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $42K.
PNC Financial Services Group first reported a position in China Biologic Products Holdings, Inc. in Q4 2014 and held it in 5 quarters.
PNC Financial Services Group's China Biologic Products Holdings, Inc. position peaked at $1.55M in Q3 2019.
84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on PNC Financial Services Group's 13F filing for Q1 2020, filed 8 May 2020.